Showing results (21-30 of 29) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 29 results.
Journal of Viral Hepatitis|May 21, 2024
Prevalence, clinical and virological characteristics and short-term prognosis of hepatitis delta infection among patients with HIV/HBV in Nouakchott, MauritaniaHélène Le Guillou-Guillemette, Adeline Pivert, Ahmed ElBara, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|September 16, 2025
Mailing Vaginal or Urine Self-Sampling Kits versus Conventional Invitation Letters: A Randomized Trial to Assess the Effect on Cervical Cancer Screening AttendanceCaroline Lefeuvre, Hélène De Pauw, Nina Dhollander, et al.
The Lancet. Global Health|February 20, 2022
Residual risk of mother-to-child transmission of hepatitis B virus infection despite timely birth-dose vaccination in Cameroon (ANRS 12303): a single-centre, longitudinal observational studyYusuke Shimakawa, Pascal Veillon, Jacques Birguel, et al.
Clinical Laboratory|September 23, 2010
Multi-center evaluation of the hepatitis B surface antigen (HBsAg) assay and HbsAg confirmatory assay for the family of Access immunoassay systemsFrançoise Lunel-Fabiani, Xavier Duburcq, Thierry Levayer, et al.
Journal of Gastroenterology and Hepatology|March 19, 2016
Different precore/core mutations of hepatitis B interact with, limit, or favor liver fibrosis severityAlexandra Ducancelle, Adeline Pivert, Sandrine Bertrais, et al.
The Lancet. Gastroenterology & Hepatology|March 16, 2025
Hepatitis B core-related antigen rapid diagnostic test for point-of-care identification of women at high risk of hepatitis B vertical transmission: a multicountry diagnostic accuracy studyJeanne Perpétue Vincent, Olivier Ségéral, Dramane Kania, et al.
Plos One|April 11, 2017
Natural non-homologous recombination led to the emergence of a duplicated V3-NS5A region in HCV-1b strains associated with hepatocellular carcinomaHélène Le Guillou-Guillemette, Adeline Pivert, Elise Bouthry, et al.
Journal of Clinical Microbiology|February 22, 2013
Multicenter quality control of hepatitis C virus protease inhibitor resistance genotypingSophie Vallet, Sylvie Larrat, Syria Laperche, et al.
Journal of Clinical Microbiology|May 1, 2015
Naturally Occurring Resistance-Associated Variants of Hepatitis C Virus Protease Inhibitors in Poor Responders to Pegylated Interferon-RibavirinSylvie Larrat, Sophie Vallet, Sandra David-Tchouda, et al.
Pageof 3